✨ Your Portfolio is fetched and updated from zerodha.
Market Cap
₹18,561 Cr.
P/E
31.29
About
Jubilant Pharmova Limited, formerly known as Jubilant Life Sciences Limited, operates globally in Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, CRDMO, Generics, and Novel Drugs busines… Read more
Jubilant Pharmova Limited, formerly known as Jubilant Life Sciences Limited, operates globally… Read more
Low
453
52W Range
High
1310
  • Jubilant Pharmova
  • Eris Lifesciences
  • Caplin Point Lab
  • TJI Pharma - API & CRAMS

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share
62 %
(as of Mar 18)
Acetic Anhydride - Domestic Market Share
0.06 %
(as of Jul 22)
Anti - Diabetes - Market Share
0.06 %
(as of Jul 22)
Cardiovascular - Market Share
0.01 %
(as of Feb 21)
Neurological - Market Share
0.02 %
(as of Jul 22)
Pharmaceutical Sector - Market Share
0.03 %
(as of Jul 22)
Vitamin & Dietary Supplements - Market Share
Revenue mix

Product Wise Break-Up

Segment Break-Up

Location Wise Break-Up - Contract Research

Location Wise Break-Up - Pharmaceuticals

Location Wise Break-Up

Operating Profit Break-Up

Capex

Asset Break-Up

Operational Metrics

    Select a Metric
    • Australia DMF fillings (.)
    • US DMF Filings (.)
    • Canada DMF fillings (.)
    • Japan DMF Filings (.)
    • Number of ANDA's Filed in USA (.)
    • Number of ANDA's Approved By USFDA (.)
    • Number of ANDA's Filed in Europe
    • Number of ANDA's Approved in Europe
    • Number of ANDA's Filed in Canada
    • Number of ANDA's Approved by Canada
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Suppliers
    • Aegis Logistics Ltd.
    • Time Technoplast Ltd.
    • Balaji Amines Ltd.
    • GMM Pfaudler Ltd.
    • Deep Energy Resources Ltd. - (Amalgamated)
    FAQs on Jubilant Pharmova Ltd. Business

    Jubilant Pharmova Limited operates globally in Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, CRDMO, Generics, and Novel Drugs with a strong manufacturing presence in Radiopharmaceutical products for regulated markets.

    Jubilant Pharmova major competitors are Eris Lifesciences, Caplin Point Lab, Alembic Pharma, Astrazeneca Pharma I, Wockhardt, Marksans Pharma, Pfizer.
    Market Cap of Jubilant Pharmova is ₹19,345 Crs.
    While the median market cap of its peers are ₹19,878 Crs.

    Jubilant Pharmova seems to be less financially stable compared to its competitors.
    Altman Z score of Jubilant Pharmova is 3.55 and is ranked 8 out of its 8 competitors.

    Company Filing
    2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Dec Mar Sep Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary Dec Mar Sep Jun Mar Jun Sep Dec Mar Jun Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Discussions & Analysis